Study Summary
This trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms may help reduce risk of and incidence of melanoma and improve cancer survival.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Up to 3 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Prevention (Educational training)
1 of 1
Experimental Treatment
121 Total Participants · 1 Treatment Group
Primary Treatment: Educational Intervention · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any remaining openings for prospective participants in this experiment?
"The study is currently open for enrolment, as evidenced by the entry posted on clinicaltrials.gov in December of 2022 and recently updated in May of that same year." - Anonymous Online Contributor
Has Educational Intervention been given the official thumbs up by the FDA?
"With only limited data attesting to its safety, our team at Power has assigned Educational Intervention a score of 2 on the scale from 1-3." - Anonymous Online Contributor
How many individuals are being included in this medical experiment?
"Affirmative. The information available on clinicaltrials.gov suggests that this experiment is actively recruiting participants; it was first posted to the site on December 1st 2022 and recently updated at the end of May, 2022. This venture needs 200000 people from one centre to take part in its research endeavours." - Anonymous Online Contributor